Promising early results for new ovarian cancer drug combo
Drug combination could offer a new option for treatment-resistant advanced ovarian cancer
Read More
Tag: The Institute for Cancer Research, London
Experts call for advanced radiotherapy funding to address COVID-19 cancer care backlog
Cancer experts urge the government to address funding gaps for high-precision radiotherapy
Read More
Researchers identify existing drug’s potential for triple negative breast cancer
Study suggests that palbociclib could be used to treat around a fifth of people with TNBC
Read More
- Liverpool and McMaster University announce £300,000 strategic research partnership
- Study finds link between malaria parasites developing antimalarial drug resistance
- Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
- Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
- US study reveals interferon combinations cause lupus symptoms and affect treatment
